Gramon Bago Uruguay
Gramon Bago Uruguay


Sodium Risedronate 150 mg - Coated tablets

ORAFIX (Risedronate) is an inhibitor of osteoclast-mediated bone resorption agent.


Each film-coated tablet contains Sodium Risedronate 150 mg.

Therapeutic Action

Prevention and treatment of osteoporosis in postmenopausal women:

In the treatment of osteoporosis Orafix increases bone mass and prevents fractures, including hip, wrist and spine fractures. Bone loss is particularly rapid in post-menopausal women under 60. Associated risk factors include: thin, early menopause, Caucasian or Asian race, family history of osteoporosis.
The administration of Orafix must be associated with an adequate intake of Calcium and Vitamin D.

How Supplied

1 coated tablet 150 mg Sodium Risedronate.

Medical Specialties

  • Rheumatology
  • Gynecology
  • Endocrinology
  • Traumatology

Active Ingredients

  • Sodium Risedronate

Export Products